Evaluating the potential impact of targeted vaccination strategies against severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) outbreaks in the healthcare setting

  1. Abdirizak, Fatima
  2. Lewis, Rayleen
  3. Chowell, Gerardo

Download
s12976-019-0112-6.pdf 3,29MB
WeightNameValue
1000 Titel
  • Evaluating the potential impact of targeted vaccination strategies against severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) outbreaks in the healthcare setting
1000 Autor/in
  1. Abdirizak, Fatima |
  2. Lewis, Rayleen |
  3. Chowell, Gerardo |
1000 Erscheinungsjahr 2019
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2019-10-07
1000 Erschienen in
1000 Quellenangabe
  • 16(1):16
1000 Copyrightjahr
  • 2019
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s12976-019-0112-6 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778978/ |
1000 Ergänzendes Material
  • https://tbiomed.biomedcentral.com/articles/10.1186/s12976-019-0112-6#Sec17 |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS) are two coronaviruses with demonstrated potential to generate significant nosocomial outbreaks. In particular, MERS continues to pose a significant threat in the Middle East since 2012. Currently, no licensed vaccine or drug treatment is available to treat patients infected with either coronavirus. However, there are some MERS vaccines in the preclinical stage of development. We sought to evaluate the potential impact of targeted vaccination strategies for mitigating SARS and MERS outbreaks in healthcare settings using simple mathematical models and detailed historic transmission trees describing the progression of past nosocomial outbreaks of SARS and MERS.
1000 Sacherschließung
lokal Infection control and prevention
gnd 1206347392 COVID-19
lokal Vaccination strategy
lokal MERS
lokal Hospital transmission
lokal Nosocomial
lokal South Korea
lokal Vaccine
lokal SARS
lokal Stochastic simulation
lokal Middle East
lokal Coronavirus
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/QWJkaXJpemFrLCBGYXRpbWE=|https://frl.publisso.de/adhoc/uri/TGV3aXMsIFJheWxlZW4=|https://frl.publisso.de/adhoc/uri/Q2hvd2VsbCwgR2VyYXJkbw==
1000 Label
1000 Förderer
  1. National Science Foundation |
  2. Biotechnology and Biological Sciences Research Council |
1000 Fördernummer
  1. 1414374
  2. BB/M008894/1
1000 Förderprogramm
  1. NSF-NIH-USDA Ecology and Evolution of Infectious Diseases program
  2. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer National Science Foundation |
    1000 Förderprogramm NSF-NIH-USDA Ecology and Evolution of Infectious Diseases program
    1000 Fördernummer 1414374
  2. 1000 joinedFunding-child
    1000 Förderer Biotechnology and Biological Sciences Research Council |
    1000 Förderprogramm -
    1000 Fördernummer BB/M008894/1
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6420295.rdf
1000 Erstellt am 2020-04-21T09:57:57.988+0200
1000 Erstellt von 122
1000 beschreibt frl:6420295
1000 Bearbeitet von 122
1000 Zuletzt bearbeitet Tue Apr 21 10:09:28 CEST 2020
1000 Objekt bearb. Tue Apr 21 10:04:26 CEST 2020
1000 Vgl. frl:6420295
1000 Oai Id
  1. oai:frl.publisso.de:frl:6420295 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source